Popular Articles
Cellulite Treatment

HPV Testing For Cervical Screening Investigated
New research, published in The Lancet Oncology, has found that combining human papillomavirus (HPV) testing with routine liquid-based cytology (LBC) screening does not increase the detection of cervical cancer compared with LBC screening alone. The trial funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme aimed to determine whether testing for HPV in the cervix might increase the effectiveness of the cervical screening programme.
generic viagra online
VIA Pharmaceuticals Announces Complete Enrollment In FDG-PET Phase 2 Study Of VIA-2291 In Cardiovascular Patients
VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, announced that it has completed enrollment in a Phase 2 clinical trial of its lead drug, VIA-2291 in patients who have experienced an acute coronary syndrome event such as a heart attack or unstable angina. The randomized, double blind, placebo-controlled study examines the impact of VIA-2291 on plaque inflammation as measured by Positron Emission Tomography with fluorodeoxyglucose tracer (FDG-PET), as well as other standard biomarkers of inflammation, over 24 weeks following such an acute event. A total of 52 patients have been enrolled in the study, which is expected to report data in the second half of 2009.
News of the day
American Lung Association Teams With CHEST Foundation To Award Clinical Research Grant Totaling $80,000 To Study Asthma
The American Lung Association and The CHEST Foundation are partnering to further clinical research to benefit the estimated 22.9 million of Americans living with asthma.
Diagnostics

Three GOP Senators Say They Will Vote Against Sotomayor Confirmation

Senate Judiciary Committee ranking member Jeff Sessions (R-Ala.) -- along with committee members John Cornyn (R-Texas) and Orrin Hatch (R-Utah) -- recently said that they will oppose Sonia Sotomayor"s confirmation to the Supreme Court, USA Today reports. The Judiciary Committee is scheduled to vote on Sotomayor"s nomination on Tuesday.In an opinion piece published Monday in USA Today, Sessions wrote that he questions Sotomayor"s "fidelity to the law," adding, "I don"t believe that Judge Sotomayor has the deep-rooted convictions necessary to resist the siren call of judicial activism. She has evoked its mantra too often." In reference to what Sessions said were discrepancies between her statements before the panel and her judicial record, he wrote, "Which Sotomayor will we get?" (Page, USA Today, 7/27).On Friday in floor remarks, Cornyn said, "While her record was generally in the mainstream, several of her decisions demonstrated the kind of liberal judicial activism that has steered the court in the wrong direction over the last few years." He added that "many of her public statements reflected a surprisingly radical view of the law." Cornyn also said that "those speeches contain very radical ideas on what the role of a judge is," noting that Sotomayor expressed a belief that there "is no objectivity in law; courts should change the law to make new policy; and ethnicity and gender can and even should impact a judge"s decision-making" (Bolton, The Hill, 7/24).Hatch, in a statement released Friday, said, "I reluctantly, and with a heavy heart, have found that I cannot support her nomination to the U.S. Supreme Court," adding, "Although Judge Sotomayor has a compelling life story and dedication to public service, her statements and record were too much at odds with the principles about the judiciary in which I deeply believe" (Stanton, Roll Call, 7/24). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):